Bridging In Vitro and In Vivo Data with a Targeted Approach to De-Risking Cell Therapy Safety in Autoimmunity
Time: 10:00 am
day: Conference Day One
Details:
- Leveraging focused in vitro binding data to select clinically relevant in vivo models for cell therapy safety assessment
- Using biochemical profiling to guide predictive model selection for autoimmune cell therapies
- Leveraging pan-autoimmunity insights to streamline model development
